More comprehensively measuring quality of life in life-threatening illness: the McGill Quality of Life Questionnaire – Expanded
S. Robin Cohen(University of Washington), Richard Sawatzky(Western University), Anne Leis(Saskatchewan Health Authority), Javad Shahidi(Daiichi Sankyo (United States)), Anne Gadermann(University of British Columbia), Lara B. Russell(Providence Health Care), Pat Porterfield, David Kuhl(Providence Health Care)
Cited by 48
Related Papers
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2021|411
Complementary and alternative medicine whole systems research: Beyond identification of inadequacies of the RCT
|Complementary Therapies in Medicine|2005|272
What Determines the Quality of Life of Terminally Ill Cancer Patients from Their Own Perspective?
|Journal of Palliative Care|2002|135
QOLLTI-F: measuring family carer quality of life
|Palliative Medicine|2006|130
Family Members’ Care Expectations, Care Perceptions, and Satisfaction with Advanced Cancer Care: Results of a Multi-Site Pilot Study
|Journal of Palliative Care|1997|99